A detailed history of Russell Investments Group, Ltd. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 190,615 shares of JAZZ stock, worth $23.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
190,615
Previous 181,406 5.08%
Holding current value
$23.3 Million
Previous $19.4 Million 9.73%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.57 - $116.37 $926,149 - $1.07 Million
9,209 Added 5.08%
190,615 $21.2 Million
Q2 2024

Aug 08, 2024

SELL
$103.94 - $118.98 $8.63 Million - $9.88 Million
-83,067 Reduced 31.41%
181,406 $19.4 Million
Q1 2024

May 08, 2024

BUY
$115.19 - $132.77 $2.46 Million - $2.84 Million
21,368 Added 8.79%
264,473 $31.8 Million
Q4 2023

Feb 05, 2024

BUY
$114.26 - $136.0 $137,226 - $163,336
1,201 Added 0.5%
243,105 $29.9 Million
Q3 2023

Nov 13, 2023

BUY
$122.0 - $145.31 $423,462 - $504,371
3,471 Added 1.46%
241,904 $31.3 Million
Q2 2023

Aug 10, 2023

SELL
$122.5 - $147.16 $806,907 - $969,342
-6,587 Reduced 2.69%
238,433 $29.6 Million
Q1 2023

May 09, 2023

BUY
$133.98 - $160.47 $3.54 Million - $4.24 Million
26,423 Added 12.09%
245,020 $35.9 Million
Q4 2022

Feb 08, 2023

SELL
$129.72 - $159.85 $2.43 Million - $3 Million
-18,749 Reduced 7.9%
218,597 $34.8 Million
Q3 2022

Nov 04, 2022

SELL
$126.59 - $161.18 $2.05 Million - $2.61 Million
-16,207 Reduced 6.39%
237,346 $31.6 Million
Q2 2022

Jul 29, 2022

SELL
$141.59 - $168.66 $3.18 Million - $3.79 Million
-22,483 Reduced 8.14%
253,553 $39.6 Million
Q1 2022

May 05, 2022

SELL
$129.64 - $160.7 $3.08 Million - $3.82 Million
-23,778 Reduced 7.93%
276,036 $43 Million
Q4 2021

Jan 21, 2022

BUY
$119.87 - $145.67 $860,546 - $1.05 Million
7,179 Added 2.45%
299,814 $38.2 Million
Q3 2021

Nov 08, 2021

BUY
$128.64 - $184.79 $2.09 Million - $3 Million
16,222 Added 5.87%
292,635 $38.1 Million
Q2 2021

Aug 04, 2021

BUY
$160.2 - $186.42 $4.83 Million - $5.62 Million
30,123 Added 12.23%
276,413 $49.1 Million
Q1 2021

May 10, 2021

BUY
$150.19 - $173.5 $7.07 Million - $8.16 Million
47,050 Added 23.61%
246,290 $40.5 Million
Q4 2020

Feb 08, 2021

SELL
$140.71 - $165.05 $6.82 Million - $8 Million
-48,471 Reduced 19.57%
199,240 $32.9 Million
Q3 2020

Nov 09, 2020

SELL
$105.46 - $144.13 $2.27 Million - $3.1 Million
-21,497 Reduced 7.99%
247,711 $35.1 Million
Q2 2020

Aug 05, 2020

BUY
$95.68 - $121.88 $9.66 Million - $12.3 Million
100,926 Added 59.97%
269,208 $29.7 Million
Q1 2020

May 06, 2020

SELL
$87.74 - $152.74 $1.5 Million - $2.6 Million
-17,044 Reduced 9.2%
168,282 $16.8 Million
Q4 2019

Jan 29, 2020

BUY
$117.65 - $153.73 $2.16 Million - $2.82 Million
18,348 Added 10.99%
185,326 $27.6 Million
Q3 2019

Nov 01, 2019

SELL
$125.18 - $143.24 $1.97 Million - $2.25 Million
-15,740 Reduced 8.61%
166,978 $21.3 Million
Q2 2019

Aug 09, 2019

SELL
$125.55 - $144.48 $391,841 - $450,922
-3,121 Reduced 1.68%
182,718 $25.8 Million
Q1 2019

May 13, 2019

BUY
$121.81 - $142.95 $5.74 Million - $6.74 Million
47,163 Added 34.01%
185,839 $26.4 Million
Q4 2018

Feb 11, 2019

BUY
$115.94 - $166.74 $728,451 - $1.05 Million
6,283 Added 4.75%
138,676 $17.1 Million
Q3 2018

Oct 26, 2018

BUY
$161.01 - $180.57 $10.3 Million - $11.5 Million
63,963 Added 93.47%
132,393 $22.2 Million
Q2 2018

Aug 08, 2018

BUY
$146.33 - $183.18 $5.33 Million - $6.67 Million
36,415 Added 113.74%
68,430 $11.8 Million
Q1 2018

May 11, 2018

BUY
$135.59 - $157.16 $2.3 Million - $2.67 Million
16,983 Added 112.98%
32,015 $4.8 Million
Q4 2017

Feb 06, 2018

BUY
$131.06 - $150.39 $246,523 - $282,883
1,881 Added 14.3%
15,032 $2.05 Million
Q3 2017

Nov 07, 2017

BUY
$142.62 - $155.6 $1.88 Million - $2.05 Million
13,151
13,151 $1.92 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.68B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.